Warnings and Withdrawals | GenomeWeb

Drugs approved since legislation to speed up the approval process at the US Food and Drug Administration are more likely to have received black box warnings or been withdrawn from the market, according to a new analysis appearing in Health Affairs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Just Easier This Way

Best Candidates

Going Well

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.